1. Yang, Qingling, Chen, Wenhui, Cong, Luping, Wei, Chenlu, Sun, Yingpu. 2023. NADase CD38 is a key determinant of ovarian aging. In Nature aging, 4, 110-128. doi:10.1038/s43587-023-00532-9. https://pubmed.ncbi.nlm.nih.gov/38129670/
2. Piedra-Quintero, Zayda L, Wilson, Zachary, Nava, Porfirio, Guerau-de-Arellano, Mireia. 2020. CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity. In Frontiers in immunology, 11, 597959. doi:10.3389/fimmu.2020.597959. https://pubmed.ncbi.nlm.nih.gov/33329591/
3. Chen, Limo, Diao, Lixia, Yang, Yongbin, Qin, F Xiao-Feng, Gibbons, Don L. 2018. CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade. In Cancer discovery, 8, 1156-1175. doi:10.1158/2159-8290.CD-17-1033. https://pubmed.ncbi.nlm.nih.gov/30012853/
4. Higashida, Haruhiro, Yokoyama, Shigeru, Munesue, Toshio, Minabe, Yoshio, Lopatina, Olga. . CD38 gene knockout juvenile mice: a model of oxytocin signal defects in autism. In Biological & pharmaceutical bulletin, 34, 1369-72. doi:. https://pubmed.ncbi.nlm.nih.gov/21881219/
5. Peclat, Thais R, Agorrody, Guillermo, Colman, Laura, van Schooten, Wim, Chini, Eduardo Nunes. . Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity. In Cardiovascular research, 120, 286-300. doi:10.1093/cvr/cvae025. https://pubmed.ncbi.nlm.nih.gov/38271281/
智鼠故事 
